BackTable Urology
Ep. 193 Bladder Cancer Innovations: ESMO 2024 Highlights with Dr. Andrea Apolo
Dr. Bogdana Schmidt
One of the things that I thought was interesting here, and I want to see what you think about that, as you mentioned on it about cisplatin versus carboplatin, is patients were able to receive cisplatin with a creatinine clearance of down to 40%. Is that your typical practice? Are you seeing patients going to split dose at 40, or do you generally cut off patients at 50?
0
💬
0
Comments
Log in to comment.
There are no comments yet.